p53's double life: Transactivation-independent repression of homologous recombination

Trends in Genetics

Volumn 20, Issue 6, 2004, Pages 235-243

  Bertrand, Pascale ^a   Saintigny, Yannick ^a   Lopez, Bernard S ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; PROTEIN P53; RAD51 PROTEIN; RAD54 PROTEIN; SINGLE STRANDED DNA;

DNA BINDING; DNA FLANKING REGION; DNA RECOMBINATION; GENE ACTIVITY; GENE CONTROL; GENE CONVERSION; GENE EXPRESSION; GENE INTERACTION; GENE REPLICATION; GENE REPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENE TARGETING; HOMOLOGOUS RECOMBINATION; MAMMAL CELL; MISMATCH REPAIR; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SEQUENCE HOMOLOGY; SPECIES DIFFERENTIATION; STATISTICAL SIGNIFICANCE; TRANSACTIVATION; VIRUS GENE; WILD TYPE;

ANIMALS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA-BINDING PROTEINS; GENOMIC INSTABILITY; HUMANS; RAD51 RECOMBINASE; RECOMBINATION, GENETIC; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 2442477786     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2004.04.003     Document Type: Review

References (70)

1. Hollstein M., et al. p53 mutations in human cancers. Science. 253:1991;49-53
2. Levine A.J., et al. The p53 tumour suppressor gene. Nature. 351:1991;453-456
3. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331
4. Purandare S.M., Patel P.I. Recombination hot spots and human disease. Genome Res. 7:1997;773-786
5. Haigis K.M., Dove W.F. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat. Genet. 33:2003;33-39
6. Amor M., et al. Mutation in the CYP21B gene (Ile-172 - Asn) causes steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. U. S. A. 85:1988;1600-1604
7. Gangloff S., et al. Homologous recombination is responsible for cell death in the absence of the Sgs1 and Srs2 helicases. Nat. Genet. 25:2000;192-194
8. Saintigny Y., et al. Homologous recombination resolution defect in Werner syndrome. Mol. Cell. Biol. 22:2002;6971-6978
9. Dominguez-Bendala J., et al. Elevated expression of exogenous Rad51 leads to identical increases in gene-targeting frequency in murine embryonic stem (ES) cells with both functional and dysfunctional p53 genes. Exp. Cell Res. 286:2003;298-307
10. Aladjem M.I., et al. ES cells do not activate p53-dependent stress responses and undergo p53- independent apoptosis in response to DNA damage. Curr. Biol. 8:1998;145-155
11. Wiesmuller L., et al. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J. Virol. 70:1996;737-744
12. Meyn M.S., et al. Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int. J. Radiat. Biol. 66:1994;S141-S149
13. Bertrand P., et al. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene. 14:1997;1117-1122
14. Mekeel K.L., et al. Inactivation of p53 results in high rates of homologous recombination. Oncogene. 14:1997;1847-1857
15. Gebow D., et al. Homologous and nonhomologous recombination resulting in deletion: effects of p53 status, microhomology, and repetitive DNA length and orientation. Mol. Cell. Biol. 20:2000;4028-4035
16. Lu X., et al. Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat. Res. 522:2003;69-83
17. Bishop A.J., et al. Atm-, p53-, and Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development. Cancer Res. 63:2003;5335-5343
18. Saintigny Y., et al. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene. 18:1999;3553-3563
19. Paques F., Haber J.E. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 63:1999;349-404
20. Lambert S., Lopez B.S. Characterization of mammalian RAD51 double strand break repair using non lethal dominant negative forms. EMBO J. 19:2000;3090-3099
21. Liang F., et al. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5172-5177
22. Wang Y.Y., et al. Carcinogens can induce homologous recombination between duplicated chromosomal sequences in mouse L cells. Mol. Cell. Biol. 8:1988;196-202
23. Akyuz N., et al. DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol. Cell. Biol. 22:2002;6306-6317
24. Gottifredi V., et al. p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1036-1041
25. Dudenhoffer C., et al. Dissociation of the recombination control and the sequence-specific transactivation function of P53. Oncogene. 18:1999;5773-5784
26. Willers H., et al. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene. 19:2000;632-639
27. Boehden G.S., et al. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair. Oncogene. 22:2003;4111-4117
28. Sengupta S., et al. BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J. 22:2003;1210-1222
29. Linke S.P., et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res. 63:2003;2596-2605
30. Cox M.M., et al. The importance of repairing stalled replication forks. Nature. 404:2000;37-41
31. Michel B., et al. Rescue of arrested replication forks by homologous recombination. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8181-8188
32. Saintigny Y., et al. Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J. 20:2001;3861-3870
33. Saintigny Y., Lopez B.S. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53. Oncogene. 21:2002;488-492
34. Janz C., Wiesmuller L. Wild-type p53 inhibits replication-associated homologous recombination. Oncogene. 21:2002;5929-5933
35. Albrechtsen N., et al. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene. 18:1999;7706-7717
36. Lee S., et al. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272:1997;7532-7539
37. Sturzbecher H.W., et al. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15:1996;1992-2002
38. Buchhop S., et al. Interaction of p53 with the human Rad51 protein. Nucleic Acids Res. 25:1997;3868-3874
39. Yoon D., et al. p53 inhibits strand exchange and replication fork regression promoted by human RAD51. J. Mol. Biol. 336:2004;639-654
40. Willers H., et al. Homologous recombination in extrachromosomal plasmid substrates is not suppressed by p53. Carcinogenesis. 22:2001;1757-1763
41. Jiricny J., Nystrom-Lahti M. Mismatch repair defects in cancer. Curr. Opin. Genet. Dev. 10:2000;157-161
42. Zink D., et al. Association of p53 and MSH2 with recombinative repair complexes during S phase. Oncogene. 21:2002;4788-4800
43. Lee S., et al. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell. 81:1995;1013-1020
44. Degtyareva N., et al. Analysis of the binding of p53 to DNAs containing mismatched and bulged bases. J. Biol. Chem. 276:2001;8778-8784
45. Subramanian D., Griffith J.D. Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucleic Acids Res. 30:2002;2427-2434
46. Dudenhoffer C., et al. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol. Cell. Biol. 18:1998;5332-5342
47. Mummenbrauer T., et al. p53 Protein exhibits 3′-to-5′ exonuclease activity. Cell. 85:1996;1089-1099
48. Susse S., et al. Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. Oncogene. 19:2000;4500-4512
49. Blander G., et al. Physical and functional interaction between p53 and the Werner's syndrome protein. J. Biol. Chem. 274:1999;29463-29469
50. Spillare E.A., et al. p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev. 13:1999;1355-1360
51. Wang X.W., et al. Functional interaction of p53 and BLM DNA helicase in apoptosis. J. Biol. Chem. 276:2001;32948-32955
52. Brosh R.M. Jr, et al. p53 Modulates the exonuclease activity of Werner syndrome protein. J. Biol. Chem. 276:2001;35093-35102
53. Yang Q., et al. The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J. Biol. Chem. 277:2002;31980-31987
54. Waldman A.S., Liskay R.M. Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology. Mol. Cell. Biol. 8:1988;5350-5357
55. Rayssiguier C., et al. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature. 342:1989;396-401
56. Radman M., Wagner R. Mismatch recognition in chromosomal interactions and speciation. Chromosoma. 102:1993;369-373
57. Jimenez G.S., et al. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26:2000;37-43
58. Bertrand P., et al. Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells. Oncogene. 22:2003;7587-7592
59. Komarov P.G., et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 285:1999;1733-1737
60. Deng C., et al. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684
61. Richardson C., et al. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene. 23:2004;546-553
62. Raderschall E., et al. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res. 62:2002;219-225
63. Schaffner D.L., et al. Retention of p53val135 wild-type function in transgenic mice. Lab. Invest. 74:1996;1005-1011
64. Cohen P.E., Pollard J.W. Regulation of meiotic recombination and prophase I progression in mammals. BioEssays. 23:2001;996-1009
65. Friedberg E.C., et al. DNA Repair and Mutagenesis. 1995;ASM Press
66. Kowalczykowski S.C., Eggleston A.K. Homologous pairing and DNA strand-exchange proteins. Annu. Rev. Biochem. 63:1994;991-1043
67. Sung P. Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science. 265:1994;1241-1243
68. Baumann P., et al. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell. 87:1996;757-766
69. Szostak J.W., et al. The double-strand-break repair model for recombination. Cell. 33:1983;25-35
70. Mohaghegh P., Hickson I.D. DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders. Hum. Mol. Genet. 10:2001;741-746